7Baggers

LifeMD Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -32.33-21.3-10.270.7511.7822.8133.8344.86Milllion

LifeMD Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 
  revenue44,859,847 38,613,911 35,946,913 33,126,335 28,119,716 31,412,469 30,458,498 29,042,837 27,416,884 24,947,199 22,313,611 18,198,112 12,893,552 11,005,763 9,089,783 4,304,812 3,944,454 3,126,727 2,698,407 2,698,990 2,184,578 2,495,424 2,037,636 1,606,491 1,471,092 2,051,734 1,107,418 424,462 985,900 1,384,429 1,227,247 1,641,028 373,349 279,884 277,353 288,277 159,649 165,469 196,611 192,429 160,526 94,676 322,903 230,258 115,560 152,115 227,566 178,536 
  cost of revenue7,414,108 4,781,506 4,548,430 4,214,969 4,067,700 4,716,842 4,635,311 5,248,175 5,567,630 5,096,487 4,200,008 3,263,253 3,985,010 2,734,936 2,190,208 1,759,639 1,257,331 680,081 655,211 677,973 639,180 439,701 534,727 355,453 415,512 535,572 329,246 203,356 677,735 942,738 700,977 1,337,942 10,065 73,988 89,503 74,216 17,001 71,605 69,156 49,090 57,123 17,475 65,668 32,331 -65,159 53,854 103,802 29,573 
  gross profit37,445,739 33,832,405 31,398,483 28,911,366 24,052,016 26,695,627 25,823,187 23,794,662 21,849,254 19,850,712 18,113,603 14,934,859 8,908,542 8,270,827 6,899,575 2,545,173 2,687,123 2,446,646 2,043,196 2,021,017 1,545,398 2,055,723 1,502,909 1,251,038 1,055,580 1,516,162 778,172 221,106 308,165 441,691 526,270 303,086 363,284 205,896 187,850 214,061 142,648 93,864 127,455 143,339 103,403 77,201 257,235 197,927 180,719 98,261 123,764 148,963 
  operating expenses                                                
  research and development1,998,015 1,498,213 1,380,686 1,183,599 1,019,163 821,636 701,070 428,333 343,416 131,160 45,413 192,228 157,936 118,346 92,325 78,142 
  sales, general and administrative                                                
  total operating expenses39,617,275 38,401,786 36,294,029 31,764,176 30,909,361 33,513,328 38,727,312 36,901,677 35,513,931 32,442,016 34,240,366 26,853,196 41,236,611 28,803,334 10,117,947 4,285,678 3,206,491 3,420,352 2,876,361 2,584,386 2,286,100 2,494,354 2,100,402 1,530,352 1,249,084 1,789,729 1,003,649 596,092 2,729,752 649,395 679,902 408,182 634,106 187,955 205,020 206,227 321,569 226,809 202,832 320,977 390,203 245,867 277,389 268,714 305,569 261,902 339,463 184,789 
  operating income-2,171,540 -4,569,381 -4,895,546 -2,852,810 -6,857,345 -6,817,701 -12,904,125 -13,107,015 -13,664,677 -12,591,304 -16,126,763 -11,918,337 -32,328,069 -20,532,507 -3,218,372 -1,740,505 -519,368 -973,706 -833,165 -563,369 -740,702 -438,631 -597,493 -279,314 -193,504 -273,567 -225,477 -374,986 -708,250 -207,704 -153,632 -105,096 -270,822 17,941 -17,170 7,834 -144,919 -132,945 -75,377 -177,638 -286,800 -168,666 -20,154 -70,787 -124,850 -163,641 -215,699 -35,826 
  net income-3,732,102 -6,122,435 -6,733,000 -10,082,915 -11,575,182 -8,438,471 -13,087,798 -13,467,609 -18,111,246 -14,353,375 -16,830,700 -11,602,383 -32,250,729 -20,622,370 -3,379,116 -2,394,728 -711,547 -943,804 -818,104 -663,747 -712,095 -548,977 -607,032 627,277 -219,582 -679,063 737,489 -1,044,805 -618,868 -226,651 -199,976 -62,049 -50,749 8,119 -21,028 1,666 -144,137 -103,904 -71,505 -140,939 -71,554 -139,366 -15,854 -41,487 -71,164 -159,341 -186,842 -28,293 

We provide you with 20 years income statements for LifeMD stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LifeMD stock. Explore the full financial landscape of LifeMD stock with our expertly curated income statements.

The information provided in this report about LifeMD stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.